Remove trials newsletter
article thumbnail

PTAB Strategies and Insights Newsletter - May 2023

JD Supra Law

The PTAB Strategies and Insights newsletter provides quarterly updates and insights into how best to handle PTAB trial proceedings at the USPTO. It is designed to increase return on investment for all stakeholders looking at the entire patent life cycle in a global portfolio. Beware of Collateral Estoppel at the PTAB - Kyocera.

Designs 98
article thumbnail

MarkIt to MarketĀ® - September 2021

JD Supra Law

The September 2021 issue of Sterne Kessler's MarkIt to MarketĀ® newsletter discusses a recent non-precedential Trademark Trial and Appeal Board decision regarding intent-to-use applications covering CBD products currently illegal under federal law, and provides cannabis legislation updates.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The PTAB Review - September 2023

JD Supra Law

In this edition, we begin with a discussion of recent trends in sanctions practice at the Patent Trial and Appeal Board (PTAB). Please see full Newsletter below for more information. Next, we summarize several recent Federal Circuit decisions addressing various aspects of PTAB practice. By: Wilson Sonsini Goodrich & Rosati

Editing 65
article thumbnail

J. Michael Keyes: "Will Bad Spaniels' New 'Disclaimer' Keep VIP Products Out Of The Doghouse?"

The TTABlog

Here is the latest literary effort from Mike Keyes , a consumer survey expert and IP litigator at Dorsey & Whitney LLP (you may subscribe to his newsletter here ). When the trial court first decided the issue of infringement in 2018, it relied heavily on a consumer survey conducted by the late Dr. Link here ).

IP 64
article thumbnail

The PTAB Review - June 2022

JD Supra Law

This issue of The PTAB Review begins with two brief updates about the power of the Patent Office Director to review Patent Trial and Appeal Board (PTAB) decisions. Next, we examine a special circumstance under which a patent can be challenged simultaneously in two different PTAB trials.

Art 52
article thumbnail

Biosimilars Patent Challenges at the PTAB: Update and Lessons Learned

LexBlog IP

On November 14, 2023, in the third webinar in Goodwin’s 2023 Biosimilars Webinar Series , Goodwin IP Litigation partner and managing editor of the Goodwin PTAB Trial Tracker newsletter, Linnea Cipriano , Goodwin IP Litigation associate and Big Molecule Watch editor, James Breen and Goodwin IP Litigation associate, Christine Potkay , will provide (..)

Patent 52
article thumbnail

PTAB Strategies and Insights - September 2021: Inter and Intra Circuit Split Emerges on Forum Selection Clauses Barring PTAB Challenges

JD Supra Law

In our May 2021 Newsletter, we discussed whether patent owners could contract away the ability for a challenger to bring Patent Trial and Appeal Board (PTAB) invalidity challenges, e.g., inter partes or post grant reviews. By: Sterne, Kessler, Goldstein & Fox P.L.L.C.